Navigation Links
Kylie Almost Doubled Earnings in Breast Cancer Year Off

Pop star Kylie Minogue earned an incredible 4.5million pounds in the year she took off while fighting breast cancer .

Despite retreating from the public eye to battle the disease, the Aussie sensation almost doubled her income from the preceding year.

According to the accounts of her company Darenote, Kylie received a salary of 1.85 million pounds, expenses of 42,366 pounds and other earnings of 2.63 million pounds.

The 39-year-old was diagnosed with cancer in May 2005; however her business showed a profit of 142,807 pounds for the year from April 2005 to March 2006.

"It is testimony to her amazing popularity that her finances remained in such good shape despite the well-publicised problems with her health," the Mirror quoted a financial expert, as saying.


'"/>




Page: 1

Related medicine news :

1. Kylie generates awareness about mammography
2. Kylies Personal Battle Against Breast Cancer May Soon Come To An End
3. Cancer Confusion over Kylie effect
4. Almost a death experience
5. Almost 30 Percent Dentists Refuse To Sign NHS Contracts
6. Bedwetting A Problem Among Almost 1 In 50 Children
7. Health Insurance For Almost Everyone In Massachusetts
8. Pregnant Women With Placental Infection Have Doubled Risk of Recurrence
9. Use of Swedish snus is Linked to a Doubled Risk of Pancreatic Cancer
10. Consensus on "Combination Therapy" for Breast Cancer
11. Breast cancer treatment to be determined by gene test
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Kylie Almost Doubled Earnings Breast Cancer Year Off

(Date:7/25/2014)... (HealthDay News) -- The human brain can preserve oxygen ... new study finds. Although dehydration significantly reduces ... found that the brain compensates by increasing the amount ... research has helped us understand a lot more about ... extreme conditions," study first author Steven Trangmar, a researcher ...
(Date:7/25/2014)... Ticket Down is a reliable source for ... at California Memorial Stadium. With the post-World Cup emotions ... organizers of the 2014 Guinness International Champions Cup have brought ... With teams representing La Liga, English Premier League, Serie A, ... best football players from around the world to 12 American ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 This ... current state of the Galactooligosaccharides (GOS) industry ... basic overview of the industry, including definitions, applications ... Chinese domestic market analysis are provided with a ... of the market. A comparison between the international ...
(Date:7/25/2014)... News) -- Babies seem to learn even before they,re ... women are 34 weeks pregnant, their unborn babies can ... a familiar nursery rhyme, the researchers report. "The ... in the developing fetus," Charlene Krueger, nursing researcher and ... Nursing, said in a university news release. "This research ...
(Date:7/25/2014)... Newyorktermlifeinsurance.org has released a new blog post ... policies. , The newly released blog post aims ... exam life insurance plans and traditional policies. The article ... to provide a simple guide for purchasing life coverage. ... be purchased online. Although traditional plans do not have ...
Breaking Medicine News(10 mins):Health News:Human Brain Has Coping Mechanism for Dehydration 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 3Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 2Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 3Health News:Rhymes Reveal Evidence of Learning in the Womb 2Health News:No Medical Exam Life Insurance and Traditional Plans - Newyorktermlifeinsurance.org Provides Quotes for All Types of Life Insurance 2
... Work and economy related stress is taking its toll on ... by American Laser Centers, the largest provider of non-invasive aesthetic services ... part in the survey (47 percent) currently feel some stress, while ... , The physical toll of their stress is also ...
... , SPRINGFIELD, Ohio, Aug. 14 AdCare Health Systems, ... term care, home care and management company, today reported financial results ... Revenues for the quarter ended June 30, 2009 were $6,613,127 as ... of $596,591. The increase was mostly due to improved occupancy in ...
... avoid becoming overweight, researchers say , FRIDAY, Aug. 14 ... obesity epidemic by forbidding their kids to eat certain foods ... may actually be making the situation worse, researchers say. ... food choices that will allow them to maintain a healthy ...
... , , SALT LAKE CITY, ... and respected brands in the nutritional supplement industry, having provided consumers ... years, is excited to announce the seven lucky winners of the ... Each grand prize winner won a 10-day vacation for two ...
... , , RICHMOND, ... TSPT ), a specialty pharmaceutical company focused on the development ... in neuroscience, today announced financial results for the three and ... Glenn A. Oclassen, President and Chief Executive Officer commented, ...
... , , , ... OXBO) today announced that the company has received approval to begin ... of Oxycyte(R) in traumatic brain injury (TBI). Oxycyte is the Company,s ... approval from Swissmedic means that we can begin enrolling patients," said ...
Cached Medicine News:Health News:AdCare Health Systems, Inc. Continues To Be Profitable; Reports 2009 Second Quarter Earning Results 2Health News:AdCare Health Systems, Inc. Continues To Be Profitable; Reports 2009 Second Quarter Earning Results 3Health News:AdCare Health Systems, Inc. Continues To Be Profitable; Reports 2009 Second Quarter Earning Results 4Health News:AdCare Health Systems, Inc. Continues To Be Profitable; Reports 2009 Second Quarter Earning Results 5Health News:AdCare Health Systems, Inc. Continues To Be Profitable; Reports 2009 Second Quarter Earning Results 6Health News:AdCare Health Systems, Inc. Continues To Be Profitable; Reports 2009 Second Quarter Earning Results 7Health News:AdCare Health Systems, Inc. Continues To Be Profitable; Reports 2009 Second Quarter Earning Results 8Health News:AdCare Health Systems, Inc. Continues To Be Profitable; Reports 2009 Second Quarter Earning Results 9Health News:AdCare Health Systems, Inc. Continues To Be Profitable; Reports 2009 Second Quarter Earning Results 10Health News:Restrictive Diet for Kids May Backfire 2Health News:Schiff Awards Seven Lucky Winners the 'Trip of a Lifetime' 2Health News:Schiff Awards Seven Lucky Winners the 'Trip of a Lifetime' 3Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 2Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 3Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 4Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 5Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 6Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 7Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 8Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 9Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 10Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 11Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 12Health News:Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results 13Health News:Oxygen Biotherapeutics, Inc. to Begin Oxycyte(R) Phase II Clinical Trials in Switzerland 2Health News:Oxygen Biotherapeutics, Inc. to Begin Oxycyte(R) Phase II Clinical Trials in Switzerland 3
(Date:7/25/2014)... NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, ... OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE ... JURISDICTION AbbVie (NYSE: ABBV ) today announced financial ... "This was another very strong quarter for AbbVie, ... original guidance and announced plans to merge with Shire, a ...
(Date:7/24/2014)... OVERLAND PARK, Kan. , July 24, 2014 ... licensing of two compounds that will be added ... agreement with Australian-based CIMTECH Pty Ltd, a biotechnology ... and PAR 122 have shown promise in bone ... a license to develop the compounds for the ...
(Date:7/24/2014)... , and MARSEILLE, France , July ... Exclusive global license from University of Tokyo enables development ... (NGS) gene panels, for blood cancers  Mutations ... indicate favorable prognosis for patients with bone marrow disorders ... for developing companion diagnostics to guide treatment with new ...
Breaking Medicine Technology:AbbVie Reports Second-Quarter 2014 Financial Results 2AbbVie Reports Second-Quarter 2014 Financial Results 3AbbVie Reports Second-Quarter 2014 Financial Results 4AbbVie Reports Second-Quarter 2014 Financial Results 5AbbVie Reports Second-Quarter 2014 Financial Results 6AbbVie Reports Second-Quarter 2014 Financial Results 7AbbVie Reports Second-Quarter 2014 Financial Results 8AbbVie Reports Second-Quarter 2014 Financial Results 9AbbVie Reports Second-Quarter 2014 Financial Results 10AbbVie Reports Second-Quarter 2014 Financial Results 11AbbVie Reports Second-Quarter 2014 Financial Results 12AbbVie Reports Second-Quarter 2014 Financial Results 13AbbVie Reports Second-Quarter 2014 Financial Results 14AbbVie Reports Second-Quarter 2014 Financial Results 15AbbVie Reports Second-Quarter 2014 Financial Results 16AbbVie Reports Second-Quarter 2014 Financial Results 17AbbVie Reports Second-Quarter 2014 Financial Results 18AbbVie Reports Second-Quarter 2014 Financial Results 19AbbVie Reports Second-Quarter 2014 Financial Results 20AbbVie Reports Second-Quarter 2014 Financial Results 21AbbVie Reports Second-Quarter 2014 Financial Results 22AbbVie Reports Second-Quarter 2014 Financial Results 23AbbVie Reports Second-Quarter 2014 Financial Results 24AbbVie Reports Second-Quarter 2014 Financial Results 25AbbVie Reports Second-Quarter 2014 Financial Results 26AbbVie Reports Second-Quarter 2014 Financial Results 27AbbVie Reports Second-Quarter 2014 Financial Results 28AbbVie Reports Second-Quarter 2014 Financial Results 29AbbVie Reports Second-Quarter 2014 Financial Results 30AbbVie Reports Second-Quarter 2014 Financial Results 31AbbVie Reports Second-Quarter 2014 Financial Results 32AbbVie Reports Second-Quarter 2014 Financial Results 33AbbVie Reports Second-Quarter 2014 Financial Results 34AbbVie Reports Second-Quarter 2014 Financial Results 35AbbVie Reports Second-Quarter 2014 Financial Results 36
... 9 Pharmacyclics, Inc.,(Nasdaq: PCYC ) today ... orally available, selective inhibitor of Bruton,s tyrosine,kinase, or ... model,for rheumatoid arthritis (RA). The data were presented ... being held this,week in Boston, MA., Researchers ...
... shows, investigational regimen resulted in 82 percent overall survival and 78 ... ... is presently being conducted in this ... patient population, LUGANO, Switzerland, June 9 In an ...
Cached Medicine Technology:Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma 2Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma 3Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma 4Sequential R-CHOP and Ibritumomab Tiuxetan (Zevalin(R)) Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreated Aggressive Diffuse Large B-cell Lymphoma 2Sequential R-CHOP and Ibritumomab Tiuxetan (Zevalin(R)) Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreated Aggressive Diffuse Large B-cell Lymphoma 3Sequential R-CHOP and Ibritumomab Tiuxetan (Zevalin(R)) Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreated Aggressive Diffuse Large B-cell Lymphoma 4
The precise, fully reusable R-100 Pullback Device is an invaluable tool during plaque volumetric analysis....
... you perform exams from cardiac to angio. ... no compromises. An ideal 31 centimeters square, ... of cardiovascular and interventional imaging. With a ... variety of vascular and interventional procedures. The ...
... The RX daytona is a fully ... field in bench top analysers offering many ... standing systems. With reusable glass cuvettes, on ... and reagents, the random access analyser can ...
Inquire...
Medicine Products: